Home › Esophageal Adenocarcinoma › Iowa › Des Moines
Esophageal Adenocarcinoma clinical trials in Des Moines, IA
3 studies for Esophageal Adenocarcinoma are looking for participants at sites in and around Des Moines (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RecruitingPhase 2/3
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Broadlawns Medical Center, Des Moines
- and 4 more
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RecruitingPhase 3
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines
- and 3 more
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RecruitingPhase 3
- Research Site, Waukee · 14 mi away
Esophageal Adenocarcinoma trials in other cities
- New York City, NY18 studies
- Boston, MA13 studies
- Houston, TX12 studies
- Arlington, VA11 studies
- Nashville, TN11 studies
- Durham, NC10 studies
- Jacksonville, FL9 studies
- St. Louis, MO9 studies
- Baldwin Park, CA9 studies
- Rochester, MN9 studies
- Queens, NY9 studies
- Los Angeles, CA9 studies
Other studies in Des Moines
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer10 studies
- Breast Cancer8 studies
- Colorectal Cancer8 studies
- Chronic Lymphocytic Leukemia8 studies
- Bladder Cancer6 studies
- Overweight6 studies
- Multiple Myeloma5 studies
- Obesity5 studies
- Acute Myeloid Leukemia5 studies
- Type 2 Diabetes5 studies
- Cardiovascular Disease5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.